Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Record History now includes new data sections (Outcome Measures, Adverse Events, Baseline Characteristics, Participant Flow) and a Quality Control status. It also notes a new revision (Revision: v3.5.0) with the date 2026-03-12.
    Difference
    1.0%
    Check dated 2026-03-19T05:59:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added revision note for v3.4.3 and removed v3.4.2 from the page's version history.
    Difference
    0.1%
    Check dated 2026-03-12T02:21:41.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Study history now shows 'Results Submitted' instead of 'No Results Posted', signaling that trial results have been submitted and may be available in the results database.
    Difference
    0.1%
    Check dated 2026-02-25T19:56:04.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Record history now includes a new entry: Revision: v3.4.2; the previous funding notice and Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T11:48:34.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new site-wide funding-status notice was added and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-04T06:24:53.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle and explanatory color-coding for changes. It also shows an updated revision label (v3.4.0) replacing the previous version (v3.3.4) and includes capitalization adjustments.
    Difference
    0.7%
    Check dated 2026-01-28T04:20:41.000Z thumbnail image

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.